Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
37,948,384
-
Share change
-
+143,577
-
Total reported value
-
$13,845,073
-
Price per share
-
$0.36
-
Number of holders
-
22
-
Value change
-
+$15,602
-
Number of buys
-
5
-
Number of sells
-
9
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q2 2019
As of 30 Jun 2019,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,948,384 shares.
The largest 10 holders included
BVF INC/IL, Senvest Management, LLC, MORGAN STANLEY, ORBIMED ADVISORS LLC, Fosun International Ltd, Delek Group, Ltd., Opaleye Management Inc., Sectoral Asset Management Inc, GEODE CAPITAL MANAGEMENT, LLC, and NEXT Financial Group, Inc.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.